Victorian government boosts biotech with A$55 million plan
This article was originally published in Scrip
The government of Victoria, Australia, has released a A$55 million dollar plan to boost its biotechnology industry through a new stage of growth.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.